A large, retrospective study conducted by scientists at The University of Texas at San Antonio (UT San Antonio) suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists medications that are widely prescribed for metabolic disease have a significantly lower risk of developing colorectal cancer compared with those taking aspirin
The adipose organ
Clinically, half-life matters for three reasons: (1) missed dosesyou may still have some drug on board for days
, L-
Its really important to understand what the FDA is doing, who the makeup of the FDA committee members are, what their backgrounds are, what their potential, if any, financial conflicts of interest are, and what their ultimate goals are as individuals and as a committee, because there may be some conflicts with respect to some of these products, Frank said
Weight loss that reduces mechanical load on joints can, in turn, improve mobility and quality of life, a connection increasingly acknowledged in research